Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

L-Threonine: The Definitive Guide

L-threonine is an indispensable amino acid used in proteins and metabolic pathways. Its WHO requirement is a total dietary value, not a supplement protocol.

Dietary requirement, studied exposure and clinical outcome answer different questions.
Published by DoserlyUpdated Next scheduled review: January 20277 min readHow this guide was made
In this guide

What is L-Threonine?

L-threonine is an indispensable amino acid used in proteins and metabolic pathways. Its WHO requirement is a total dietary value, not a supplement protocol. The dietary requirement describes total intake from foods and supplements combined; it does not prescribe a powder. [1]

Typical L-Threonine Research Protocols

Research schedules only; these are not prescriptions.
Source and populationForm and amount per administrationFrequencyTotal exposureDuration or window
Matsumoto 2025 · 30 healthy men recruited; 24 completedL-threonine 3, 6, 9 then 12 g/dayRecommended divided 1–3 times/day; actual frequency not fixedUp to 33 capsules/day at 12 g4 weeks per level, ≥2-week washouts
Tandan 1996 · 95 people with ALSL-threonine 4 g/day plus pyridoxal phosphate 160 mg/dayDaily totals; number of administrations not recoveredCombination arm6 months

These rows reproduce studies. Do not average their populations, forms, frequencies or durations into one regimen.

Dietary requirement, studied exposure and clinical claim remain separate. Sources: WHO report · Primary human study.

Should L-Threonine be cycled?

No verified trial establishes a cycle. A review point can limit indefinite use, but it does not prove a physiological reset.

What happens when it is stopped?

No withdrawal syndrome is established. An acute or short study cannot predict persistence after stopping.

Which foods provide it?

Meat, fish, eggs, dairy, soy and other legumes provide indispensable amino acids within complete protein matrices. Portions and digestibility vary; a value in mg/kg/day concerns total dietary intake. [1]

Which forms and label details matter?

Products generally use free L-threonine in capsules or powders, or include it within EAA blends. Record grams per daily total and number of capsules. In the 2025 tolerance trial, participants swallowed 33 capsules per day at the highest level and were advised to divide them one to three times; the actual number of administrations was not fixed.

How should it be stored?

Follow the finished-product label, close the container and protect it from moisture and heat. Keep the lot number and discard a product with a broken seal or unexplained change.

What is L-Threonine commonly used for?

Threonine is marketed for gut, collagen, immune and neurologic support. The current primary set mainly addresses short-term tolerance. A six-month ALS trial did not show clinical benefit and raised a disease-specific pulmonary-safety concern that cannot be generalized to healthy users.

What does human research show?

The 2025 randomized crossover tolerance study called 12 g/day the study-specific NOAEL after four weeks per dose in healthy men. That highest tested dose is not an official UL or an efficacy regimen, and industry links should be weighed. [2] In ALS, threonine 4 g/day was combined with 160 mg/day pyridoxal phosphate. The six-month trial found no benefit, and forced vital capacity declined faster than placebo; the design cannot attribute that signal to threonine alone or export it to healthy people. [3]

Conceptual hierarchy connecting mechanism, human study and clinical outcome.
An acute study, biomarker, tolerance study and clinical outcome answer different questions.

How might it act?

As an indispensable amino acid, L-Threonine contributes to protein synthesis and specific metabolic pathways. A normal biochemical role does not establish that a concentrated dose improves symptoms in someone whose intake is adequate.

What are the risks and interactions?

Large capsule burdens can create adherence and swallowing problems. The healthy-male tolerance trial was short, while the ALS study used a co-ingredient in a disease population. Neither defines chronic safety for the public. Seek review for neurologic disease, pregnancy, breastfeeding, childhood use, or kidney or liver disease.

Which medicines can interact?

Product-specific interaction data are limited. Have the complete formula reviewed by a pharmacist when taking medicines, especially for neurologic, psychiatric, metabolic, kidney or liver conditions. Do not invent a universal separation interval.

Regulatory status: In the United States, supplements are not routinely approved for efficacy before sale. In Canada, check the NPN or DIN-HM and licensed label conditions. [4], [5]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, dietary context, symptoms and intended outcome. Set a review date before starting.

Stop and seek advice for an allergic reaction, persistent vomiting, unusual weakness, confusion or another severe symptom.

What do public communities report?

Public discussions often emphasize taste, timing and felt effects while omitting lot, total diet and validated outcomes. This update did not independently recrawl or quantify those posts.

How does L-Threonine compare?

OptionWhat it suppliesLimit
L-ThreonineOne defined amino acidDoes not replace complete protein
EAAsAll nine indispensable amino acidsFormula varies
BCAAsLeucine, isoleucine and valineSix EAAs are absent
Complete proteinAll EAAs in a protein matrixPortion and digestibility vary

Common questions about L-Threonine

Does threonine improve ALS?

No. A six-month trial of threonine plus pyridoxal phosphate found no clinical benefit.

Can the pulmonary signal be blamed on threonine alone?

No. The disease population and co-ingredient prevent attribution, and the finding cannot be exported to healthy adults.

Does 12 g/day define an upper limit?

No. It was the study-specific four-week NOAEL in a short healthy-male tolerance trial.

Why does capsule count matter?

The highest trial level required 33 capsules per day, which affects adherence and swallowing risk.

Was the dose always divided three times daily?

No. Division one to three times daily was recommended, but actual administration frequency was not fixed.

What should I track?

Record free L-threonine, capsule count, each administration, daily total, co-ingredients, swallowing or GI issues and review date.

Glossary

Plain terms for interpreting the evidence.

Indispensable amino acid
An amino acid the diet must provide.
Dietary requirement
Total required intake; not a supplement dose.
Amount per administration
Amount consumed at one time, distinct from daily total.
NOAEL
Highest tested level without an observed adverse effect in one study; not automatically a UL.
UL
Tolerable Upper Intake Level established by an authority.
Biomarker
Biological measure that is not necessarily a felt or clinical benefit.

How this guide was researched

The complete WHO report, accessible primary human studies and live NCBI metadata were read on October 9, 2026. Titles, authors, journals, DOI, PMID, available PMCID and CommentsCorrections were checked. Open full text supplied methods details; an unreported frequency was not guessed. [1], [2], [3], [4], [5]

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources

Sources preserve form, dose, frequency, population, duration and outcome.

Showing 5 sources

  1. 01

    Protein and amino acid requirements in human nutrition: report of a joint WHO/FAO/UNU expert consultation ↗

    Official expert report

    Current primary source and identity checked; limitations are retained in the text.

    Detail: Adult dietary requirement: 15 mg/kg/day; it is not a supplement dose.

  2. 02

    Evaluation of safe utilization of L-threonine for supplementation in healthy adults: a randomized double blind controlled trial. ↗

    Randomized crossover tolerance trial

    Current primary source and identity checked; limitations are retained in the text.

    Detail: 3–12 g/day for four weeks per level; advised in one to three divided administrations.

  3. 03

    A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. ↗

    Randomized disease-population trial

    Current primary source and identity checked; limitations are retained in the text.

    Detail: Threonine 4 g/day plus pyridoxal phosphate 160 mg/day for six months; no benefit.

  4. 04

    Questions and Answers on Dietary Supplements ↗

    U.S. regulatory overview

    Current primary source and identity checked; limitations are retained in the text.

    Detail: Dietary supplements are not routinely FDA-approved for efficacy before sale.

  5. 05

    Product Licensing ↗

    Canadian licensing overview

    Current primary source and identity checked; limitations are retained in the text.

    Detail: Canadian authorization attaches to the licensed finished product and label conditions.